Back
ProShares Ultra Communication Services Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
70
LTL
ProShares Ultra Communication Services
Last Price:
85.75
Seasonality Move:
3.64%
Buy
58
SRPT
Sarepta Therapeutics
Last Price:
133.49
Seasonality Move:
14.88%
Buy
70
ProShares Ultra Communication Services (LTL)
is a Buy
Is ProShares Ultra Communication Services a Buy, Sell or Hold?
- The current ProShares Ultra Communication Services [LTL] share price is $86.66. The Score for LTL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- LTL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LTL Stock Price Chart
What is ProShares Ultra Communication Services's stock price today?
-
The ProShares Ultra Communication Services share price today is $86.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LTL is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $133.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
LTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.51 | Buy |
| Relative Strength Index (14 RSI): | 70.06 | Buy |
| Chaikin Money Flow: | -5 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.03 - 85.63) | Buy |
| Bollinger Bands (100): | (65.86 - 79.02) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 63.54 | Buy |
| Chaikin Money Flow: | -725343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.85 - 129.81) | Buy |
| Bollinger Bands (100): | (119.21 - 141.67) | Buy |
LTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.12 | Buy |
| 20-day SMA: | 83.22 | Buy |
| 50-day SMA: | 77.79 | Buy |
| 200-day SMA: | 67.67 | Buy |
| 8-day EMA: | 85.17 | Buy |
| 20-day EMA: | 83.01 | Buy |
| 50-day EMA: | 78.6 | Buy |
| 200-day EMA: | 67.96 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 119.83 | Buy |
| 20-day SMA: | 118.14 | Buy |
| 50-day SMA: | 122.33 | Buy |
| 200-day SMA: | 130.09 | Buy |
| 8-day EMA: | 123.82 | Buy |
| 20-day EMA: | 120.48 | Buy |
| 50-day EMA: | 122.96 | Buy |
| 200-day EMA: | 126.17 | Buy |
ProShares Ultra Communication Services Earnings Growth & LTL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
ProShares Ultra Communication Services Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||